International Cannabis Business Conference Blog – Page 8 – International Cannabis Business Conference

Italy Issues Authorization To Distribute Medical Cannabis Flower

Written by Johnny Green on June 28, 2025. Posted in Business, Policy.

Against the backdrop of an ongoing legal battle between Italy’s ‘cannabis light’ industry and the Italian government, regulators in Italy have reportedly issued an authorization to Tilray to distribute medical cannabis flower for therapeutic use.

“Tilray’s wholly-owned subsidiary, FL Group, has become the first company in Italy to receive official authorization from the Ministero della Salute (Italian Ministry of Health) to import and distribute proprietary Tilray Medical-branded medical cannabis flower for therapeutic use.” Tilray stated in a company press release.

The company is approved to distribute flowers containing the following cannabinoid content in Italy:

Cannabis Flowers 25%
Cannabis Flowers 18%
Cannabis Flowers 9% / CBD 9%

Meanwhile, Italian companies that distribute hemp-derived products are vowing to continue to operate despite the legal uncertainties involved. Earlier this month, Italian lawmakers approved a ban on cannabis light products.

A ‘security decree’ measure received final passage by Italy’s Senate in early June by a vote of 109-69. In addition to the ban on cannabis light, the measure also involved several other provisions championed by Prime Minister Giorgia Meloni’s right-wing coalition government, including the introduction of 14 new crimes.

“It bans the trade of “cannabis light”, or hemp, which unlike marijuana has no mind-altering qualities, infuriating local entrepreneurs who say the move will cost thousands of jobs and imperil millions of euros of investments.” reported Reuters in its original coverage at the time.

All processing, distribution, trade, and transport of ‘cultivated hemp inflorescences’ is, in theory, prohibited under Italian law, although industry and policy advocates point out that the new law is in direct conflict with European Union policies.

“Italian industrial hemp dealers are regularly operating and their businesses have never closed. They will work as they always worked before the entry into force of Article 18 of the Security Decree.” reported DolceVita about comments made by Negozianti Italiani Canapa (translated from Italian to English).

“Basically, to date, a definitive decision on the issue of industrial hemp, effectively does not exist. There was no warning for commercial activities, there were no indications on how to act towards the products, much less towards the fiscal area. Also for this reason we shopkeepers, arrogate to ourselves the legitimacy to continue working exactly as before.” the outlet also reported.

Ultimately, the situation in Italy will take a while to play out before the various sectors of the emerging industry know what they are truly dealing with. In the meantime, the landscape will continue to shift, and selective enforcement by the Italian government will presumably occur to some degree.

European Industrial Hemp Association Announces Leadership Change

Written by Johnny Green on June 28, 2025. Posted in Business, Policy.

The European Industrial Hemp Association (EIHA) is one of the most established, respected, and important organizations on the planet. EIHA is the only pan-European membership organization in the industrial hemp sector and represents the common interests of hemp farmers, producers, and traders working with hemp fibers, shives, seeds, oil, leaves, and cannabinoids.

The organization’s main task is to represent, serve, and protect the hemp sector in the European Union and international policymaking. EIHA focuses on the different areas of the application of hemp, including its use for textiles, construction materials, paper, cosmetics, feed, food, and supplements.

EIHA recently announced a big change in the organization’s leadership. Below is more information about the leadership change via a press release from the organization:

The European Industrial Hemp Association announces an important leadership change: Lorenza Romanese will be stepping down as Managing Director, and Francesco Mirizzi, currently Senior Policy Advisor at EIHA, will take over the role.

Mr Mirizzi has been part of the EIHA team for the past five years, where he has worked closely with members and stakeholders on all policy files. His expertise spans key dossiers such as feed, construction, food, and the Common Agricultural Policy (CAP) is especially timely, as these dossiers are currently in active development at the EU level. His leadership comes at a crucial moment and positions EIHA strongly for the next phase of advocacy and growth.

Ms Romanese, who has led EIHA since 2019, was instrumental in establishing the association’s Brussels presence and building up its influence at the EU level. Her strategic vision and relentless commitment over the past six years helped position hemp as a serious and growing sector in Europe. “It has been a privilege to lead EIHA through these transformative years. I am proud of what
we’ve achieved together. Francesco’s leadership comes at the right time—his topics are hot and his expertise unmatched. I’m not going far—I’ll continue to support Francesco, the board, and all of you as an advisor, especially on the Novel Food Consortium.” – she states.

While stepping back from the day-to-day role, Ms Romanese will remain involved with EIHA, as a senior advisor, continuing to support the Novel Food Consortium. She will stay on board part-time to advise on strategy and the next steps for the Novel Food applications in the EU and in the UK.

This announcement comes after the EIHA General Meeting on the 11th of June. While negotiations were already underway, Ms. Romanese was still in the middle of the transition process and no formal announcement was made. With everything now confirmed, we are pleased to share the news.

Monica Solano Leon will remain a central point of contact for members, continuing to handle administration, Consortium coordination, and general support. Monica’s continuity ensures stable operations and consistent communication for the entire EIHA network.

We welcome this change with optimism and trust you will receive it with the same enthusiasm as we do. Mr Mirizzi has our full confidence – his dedication, insight, and collaborative spirit have already proven invaluable, and we are eager to see his leadership in action. “I am honoured to step into this role and build on the incredible work Lorenza has done. As the policy landscape
evolves, EIHA must stay proactive, informed, and united. I look forward to working closely with our members and partners to strengthen our voice and impact in Brussels.” – Mr Mirizzi affirms. “In the coming year we will focus on clarifying once and for all the legal status of all parts of hemp, accelerating the Novel Food applications and further increasing awareness of the potential of hemp in the bioeconomy sector” – he adds.

We thank Ms Romanese warmly for her remarkable contributions over the past six years, and we look forward to continuing this journey with Mr Mirizzi leading the way.

frankfurt germany frankfurt germany frankfurt germany frankfurt germany

Youth Cannabis Consumption In Frankfurt Is At An All-Time Low

Written by Johnny Green on June 27, 2025. Posted in Policy.

According to a preliminary evaluation of the 2024 Monitoring System Drug Trends (MoSyD) study, cannabis consumption among young people in Frankfurt has reached an all-time low. The study’s findings provide insight into consumption rates in a post-legalized Germany.

“According to an initial analysis of the Drug Trend Study 2024, only 22 percent of 15- to 18-year-olds have recently tried cannabis at least once in their lives. This means that the number of users has halved over the past ten years and fallen to its lowest level since the study began in 2002.” the City of Frankfurt wrote in a press release on its website (translated from German to English).

“Frankfurt is on the right track,” says Elke Voitl, Head of the Department of Social Affairs and Health. “We have strengthened the city’s prevention and counseling services, especially to inform young people and support them with problems related to cannabis use.”

Germany implemented the first provisions of the nation’s CanG law on April 1st, 2024, as part of a multi-phased adult-use legalization model. The first phase of the model involved permitting adults in Germany to cultivate, possess, and consume personal amounts of cannabis. Starting on July 1st, 2024, adults in Germany can apply to launch a noncommercial cultivation association.

The remaining component of Germany’s legalization model, often referred to as ‘Pillar 2,’ involves launching regional adult-use cannabis commerce pilot research projects. The launch of pilot projects has experienced various delays, although 49 applications have been submitted so far.

“The fears that partial legalization would be accompanied by an increase in consumption among adolescents and young adults have not been confirmed. According to our representative survey, all consumption figures have decreased. This applies to both lifetime prevalence and data on current and frequent consumption.” states the Frankfurt study’s leader Professor Bernd Werse.

“Ever since the traffic light coalition announced its intention to partially legalize cannabis at the end of 2021, the prevalence of the drug among young people has fallen to new lows, a trend that has continued after the introduction of the cannabis law. Fears that legal status would send the ‘wrong signal’ to young people have therefore not been confirmed—quite the opposite,” Professor Werse also stated.

“We welcome the fact that partial legalization for adults has not led to an increase in consumption. Our focus remains on education, dialogue, and destigmatizing users,” emphasized Oliver Müller-Maar, Acting Head of the Drugs Department.

“Decriminalization and controlled distribution offer the opportunity to better reach users and reduce the risks of consumption. The goal remains a responsible approach to cannabis that takes into account both health protection and social reality.” stated Health Minister Voitl, according to the City of Frankfurt’s press release.

Professor Dr Karl Lauterbach BMG Thomas Ecke photo

Former German Health Minister Continues To Promote Regulation Over Prohibition

Written by Johnny Green on June 27, 2025. Posted in Policy.

Professor Dr. Karl Lauterbach is a German physician, epidemiologist, and health economist who has served as a Social Democrat (SPD) lawmaker since 2005. Dr. Lauterbach also served as Germany’s Federal Minister of Health from 2021 to 2025 before being succeeded by Minister Nina Warken last month.

During his tenure as Germany’s Health Minister, Dr. Lauterbach led the effort to lobby the European Union to allow his country to legalize cannabis for adult use. He advocated for Germany to be able to adopt and implement a legalization model similar to Canada’s recreational legalization model, including national recreational cannabis sales to adults.

Unfortunately, the EU did not allow Germany to proceed with robust nationwide adult-use cannabis sales, citing current European Union agreements that prohibit such commerce. However, Dr. Lauterbach and other German lawmakers did succeed in approving and implementing a scaled-back version of adult-use legalization, the initial provisions of which took effect on April 1st, 2024.

Former Minister Lauterbach continues to advocate for cannabis industry regulation over prohibition in Germany, as evidenced by comments that he made during a recent podcast. The comments were reported in the German Cannabis Business Association’s (BvCW) recent newsletter.

“It would of course be much better if the cultivation associations could offer it [cannabis]. On the other hand, you also have to say the following: a lot of these people who get something prescribed there also have some kind of medical problem and, if that is the case and they have to pay for it themselves, then I prefer that the person with a medical problem gets the cannabis from the pharmacy. […]” BvCW credited Dr. Lauterbach as saying (translated from German to English).

So it’s not perfect, of course, but you have to look at the alternatives. Those who get high-quality cannabis using this prescription […] are otherwise supplied by […] criminals.” Dr. Lauterbach also stated.

Germany’s legal medical cannabis industry continues to expand at a staggering rate, as demonstrated by new medical cannabis import numbers. In the first quarter of 2025, Germany imported over 37.223 metric tonnes of medical cannabis products.

To put that figure into perspective, the total imports for Q1 2025 increased by roughly 14.8% compared to the Q4 2024 total (32.419 metric tonnes), which was itself a record at the time. Q1 2025’s import total is an increase of over 457% compared to the same period one year ago. Germany imported 8.143 metric tonnes of medical cannabis products in Q1 2024.

Since the launch of initial sales in 2017, safe access to medical cannabis via Germany’s pharmacies has increased significantly, as evidenced by statistics previously provided by the German Cannabis Business Association.

“Patients can order cannabis online with a private prescription and have it delivered to their home. Nationwide, around 2,500 of the 17,000 pharmacies now offer medical cannabis,” BvCW stated (translated from German to English). “The industry’s revenue is now estimated at around half a billion euros.”

A recent newsletter by leading international cannabis economist Beau Whitney, founder of Whitney Economics, provides additional German market data. In Beau Whitney’s newsletter, Whitney Wire, he described how Germany has traditionally had a strong legal medical cannabis market. Even before the adoption of the nation’s CanG law in April 2024, which removed cannabis from Germany’s Narcotics List, Germany was already home to the largest legal medical cannabis market in Europe.

But after the CanG law’s adoption, safe access greatly improved for German medical cannabis patients, and thanks in large part to the rise of medical cannabis telemedicine, Germany’s legal patient base has increased exponentially.

“There has been a consistent number of between 200k – 300k medical patients.” Beau Whitney writes. “As a result of this new innovation, there is now an additional 500k – 600k self-paying consumers participating in the legal market.”

“When combined with 100k cultivation association members, there is approximately 800k legal consumers in the German market right now. For perspective, 800k consumers represents between 10% and 20% of the total market, while the supply and capacity at the end of 2024 represented nearly 15% of all of the supply that the market needs.” Whitney stated.

(The featured image for this article is from BMG/Thomas Ecke)

New UN Drug Report Demonstrates Cannabis Prohibition’s Ineffectiveness

Written by Johnny Green on June 27, 2025. Posted in Policy.

The United Nations has published its 2025 World Drug Report. Included in it is the statistic that an estimated 244 million people are cannabis consumers. While the United Nations Drug Report is saturated with drug war rhetoric, that single statistic demonstrates how ineffective cannabis prohibition policies are when it comes to deterring cannabis use.

Humans have consumed parts of the cannabis plant for thousands of years, and there is no evidence demonstrating that prohibiting cannabis has stopped humans from using cannabis. Conversely, there is considerable evidence that cannabis prohibition policies have harmed a massive list of human lives.

In addition to determining that the world is home to 244 million cannabis consumers, the report also lists the following about cannabis:

76% of cannabis consumers are men, 24% are women
5,749 tons of cannabis flower were seized in 2023, down 8% compared to the previous year
1,236 tons of cannabis ‘resin’ were seized in 2023, up 4% compared to the previous year
Africa accounted for 44% cannabis seized worldwide in 2023
Cannabis has increased by 34% over the past decade
Cannabis use remains highest in North America

“Trafficking in cannabis herb remains mostly an intraregional issue in Western and Central Europe; there continue to be, however, substantial imports of cannabis resin into the subregion from North Africa.” the report stated.

The report places a heavy reliance on the number of people in drug treatment for cannabis as a measurement for ‘growing concerns’ about the substance. However, the report does not mention how many of those people are voluntarily in drug treatment for cannabis versus being forced to go to drug treatment for cannabis against their will.

As part of prohibition penalties in many jurisdictions, people caught with cannabis are forced into drug treatment, whether they truly have a cannabis use problem or not. Using my father as an example, one of the times that he was caught with cannabis, he was forced into drug rehab even though he wasn’t a cannabis consumer for many years at that point.

Despite the rehab staff never finding cannabis in my father’s system via their ongoing drug tests, my father was determined to have ‘problematic cannabis use disorder’ and he was forced to continue with weekly rehab appointments, with each appointment involving a hefty fee to both the rehab facility and the government.

This is important context that needs to be considered whenever cannabis-based drug treatment data is reported, like what is included in the UN report. Cannabis prohibition does not work and harms lives. Regulation is a much more sensible approach to cannabis policy.

Nearly Half Of Australians Support Cannabis Legalization

Written by Johnny Green on June 26, 2025. Posted in Policy.

Nearly half of Australian adults (48%) now support modernizing the nation’s policies to permit adult-use cannabis activity, according to a recent poll conducted by Roy Morgan. The poll found that support for recreational cannabis legalization in Australia has increased by 15% over the last ten years.

“Opposition has fallen to 41%, also down 15 points since 2015 (from 56% and 49% in 2019), while 11% remain undecided. The latest figures reflect a decisive shift in national sentiment towards legalisation.” the pollsters stated.

“Over 69,000 Australians were asked: “In your opinion should the smoking of marijuana be made legal – or remain illegal?” from April 2024 to March 2025.” Roy Morgan also wrote on its website regarding their poll.

Similar to polls conducted in other regions, younger adults were more likely to express support for legalization. Fifty-four percent of Australians aged 18-24 indicated that they support such a policy change, and 58% of Australians aged 25-34 support legalization. For the 25-34 year old category, support has increased by 24% compared to a decade ago.

Only 36% of polled Australians aged 65 and over support legalization. However, that is an increase compared to 2019, when 33% in the age category expressed support. Forty-eight percent of polled Australians aged 50-64 support legalization, which is a 19% increase since 2019.

“Analysis shows support for the legalisation of marijuana now varies clearly by region, with both Australian territories in favour. The N.T leads with 57% in favour (35% opposed), closely followed by the ACT (which decriminalised personal possession and cultivation on 31 January 2020) at 56% in favour (36% opposed).” Roy Morgan stated. “Tasmania shows strong backing at 52% (36% opposed), and Queensland records majority support at 51% (39% opposed). It’s worth noting that these are the only two states where the regional population is larger than the urban population.”

“Australia’s debate on marijuana legalisation continues to evolve. With nearly half of Australians now in favour, the national mood has shifted significantly over the past decade. While younger adults lead the charge for change, notable opposition remains, especially among older and teenage groups. International trends (including further US state legalisations) and local policy discussions, such as the ACT’s earlier reforms, continue to influence public attitudes. These results highlight how attitudes are diversifying across age cohorts as Australia considers its next steps.” Roy Morgan CEO Michele Levine said.

In New South Wales (NSW), a recent parliamentary report recommended that the government decriminalize cannabis possession and use by adults. The report has yielded calls by lawmakers in NSW to enact the policy change.

“NSW government members have suggested cannabis reform is inevitable in the state after a parliamentary inquiry found the current regime is discriminatory because people with means can obtain medicinal cannabis legally while others are criminalised.” The Guardian reported in its original coverage.

“The NSW upper house inquiry released its landmark report into the effectiveness of cannabis regulation last week. The recommendations to decriminalise and consider legalisation were backed by six of the seven committee members – including Labor, Liberal and crossbench legislative council members. One Liberal member voted against the recommendations.” the outlet also reported.

A recent analysis by Research and Markets found that “the Australia legal cannabis market was valued at USD 126.32 million in 2024 and is expected to reach USD 420.33 million by 2030, rising at a CAGR of 22.16%.”

New Zealand Clinical Trial Recruiting Dogs For Cannabis Research

Written by Johnny Green on June 25, 2025. Posted in Science.

More countries are now home to medical cannabis legalization, to some degree, than countries that still prohibit medical cannabis. Laws in legal medical cannabis countries range from being very limited to permitting robust commerce and home cultivation options for suffering patients.

An emerging area of medical cannabis policy, regulation, and research goes beyond humans and extends to medical cannabis therapies for pets and other animals. A recent example of this can be found in New Zealand, where researchers are recruiting dogs for a clinical trial examining medical cannabis and its potential to treat pain.

“More than 100 dogs are being recruited for a world-first cannabis clinical trial to help canines suffering from osteoarthritis.” reported The New Zealand Herald in its local coverage. “A New Zealand veterinary pharmaceutical company behind the “groundbreaking” medicine is seeking dogs across Waikato, Bay of Plenty and Christchurch for the six-week experiment.”

Medical cannabis for animals is an underrated sector of the emerging legal cannabis industry and possesses tremendous profit potential for innovative entrepreneurs and savvy cannabis industry investors.

Industry analysts at Research and Markets recently projected that the CBD pet market size alone is expected to reach $1.72 billion by 2030 and increase at a compound annual growth rate of 32.47% between now and then. This, of course, does not take into account other cannabinoids and non-pet animals like farm livestock.

Researchers estimate that there are over 900 million pet dogs globally, and another 370 million pet cats. In the United States alone, pet owners spend an estimated $136 billion on pet products annually. Add to the mix tens of billions of cattle, sheep, goats, chickens, pigs, and other livestock around the world, and the potential market for medical cannabis wellness products for animals is off the charts.

In separate dog and medical cannabis research news, the results of a study focusing on medical cannabis therapies and dogs with osteoarthritis and conducted by the Federal University for Latin American Integration in partnership with the Santa Cannabis Association, will reportedly be featured in the scientific journal Frontiers in Pharmacology soon.

“The research showed that the plant extract relieves pain, improves mobility and the quality of life of animals — and most importantly, without serious side effects.” reported Sechat about the research effort (translated from Portuguese to English).

Thailand Is Moving Backwards On Cannabis Policy

Written by Johnny Green on June 25, 2025. Posted in Business, Policy.

Thailand adopted a historic measure in 2022, which involved the removal of cannabis from the nation’s narcotics list, making it the first nation in the region to do so. However, that policy change is proving to be short-lived, with the nation’s Public Health Minister Somsak Thepsutin confirming this week that he signed a measure that will place cannabis back on the narcotics list.

“Public Health Minister Somsak Thepsutin said on Tuesday he had signed an order restricting cannabis use to strictly medical purposes.” reported the Bangkok Post in its local coverage. “People wanting to purchase cannabis would in future have to present a doctor’s prescription and a medical certificate detailing their condition, Mr Somsak said.”

“The director-general of the Department of Thai Traditional and Alternative Medicine, Somlerk Jeungsmarn, said on Monday that authorities would allow a grace period before changes come into effect, so the parties concerned could prepare for it.” the outlet also reported.

The announcement was expected, albeit unfortunate, with government officials in Thailand having repeatedly indicated in recent months that they would implement the regressive approach to cannabis policy and regulation. The recently signed order will take effect when it is published in the Royal Gazette, although the exact date of publication is still unclear. Thailand’s emerging cannabis industry is currently estimated to be worth over $1 billion.

Part of the shift in regulations will involve the requirement that all shops have a licensed medical professional on their staff, and that shops must complete and pass monthly inspections. Any cannabis shops in Thailand found to be out of compliance two times will lose their license to operate.

As we previously reported, a ramp-up in cannabis shop inspections has already begun in Bangkok, Thailand, where the Ministry of Public Health, the Narcotics Suppression Bureau, and the Office of the Narcotics Control Board collaborated to deploy over 100 officers in a coordinated sweep of 20 shops.

“A group of cannabis advocates said Wednesday that the change in regulations was politically motivated. The group said they will rally at the Health Ministry next month to oppose the change and the attempt to make it a criminal offense again to consume or sell cannabis.” reported the Associated Press regarding pushback by local cannabis advocates.

Medical Cannabis Is Now Available In Costa Rica

Written by Johnny Green on June 24, 2025. Posted in Business.

Safe access to medical cannabis has finally become a reality in Costa Rica, where suffering patients diagnosed with qualifying conditions can now make legal purchases from the nation’s pharmacies. Legal purchases will require a prescription, although local advocates are working to increase legal medical cannabis commerce options.

The push for increased safe access in Costa Rica via permitting dispensaries to operate is being opposed by leaders of the domestic pharmacy industry.

“The pharmaceutical industry insists that this regulation seeks to protect patients, ensuring that therapeutic cannabis is dispensed by specifically trained professionals and under pharmaceutical supervision.” reported The Costa Rica News.

“The possibility of sales in dispensaries should not be open. These products cannot be sold over the counter, as they pose risks such as drug interactions, adverse effects, or misuse,” stated Dr. Andrés Guzmán Tacsan, representative of the Costa Rican College of Pharmacists, according to The Costa Rica News.

Medical cannabis advocates in Costa Rica point out that not all of the nation’s pharmacies are willing to carry medical cannabis products, and that dispensaries would help ensure that there is enough availability for all qualifying patients.

They also point out that giving a virtual monopoly to pharmacies by not permitting dispensaries to operate limits Costa Rica’s emerging cannabis industry’s potential. Entrepreneurs and investors are largely locked out of Costa Rica’s industry under the current framework.

Pharmacists in Costa Rica who are advocating for medical cannabis to only be dispensed by pharmacists in pharmacies, due to previously mentioned concerns, fail to recognize that medical cannabis dispensary staffers specialize in medical cannabis and are very knowledgeable. Compare that to a pharmacist who may have little to no experience or background with medical cannabis specifically.

A potential compromise may be to require aspiring dispensary owners and staff to complete a certain type of training or certification to establish that a standard of accreditation has been met, which is what many state-level markets in the United States require. For now, qualifying patients have at least some level of safe access to their medications.